Stoke Therapeutics, Inc. (STOK)

SEC filing

Stoke Therapeutics, Inc.

STOK · CIK 1623526

4 · Dec 3, 2025 · Allan Jonathan sold 4,576 shares at $30.22/share ($138.3K); exercised options for 12.36K shares

Allan Jonathan sold 4,576 shares at $30.22/share ($138.3K); exercised options for 12.36K shares

xslF345X05/form4-12042025_011223.xml

xslF345X05/form4-12042025_011223.xmlSEC.gov

Graphics and non-inline formats (not embedded below).